ONE DRUG FOR ONE BUG: DEBIOPHARM TO DISCUSS THE POTENTIAL OF PATHOGEN-SPECIFIC ANTIBIOTICS AT THE 2022 WORLD AMR CONGRESS
International health authorities, such as the WHO and the CDC are warning of the emerging danger of bacterial infections resistant to current antibiotics The 2022 World Anti-Microbial Resistance (AMR) Congress in the greater Washington D.C. area is serving as a forum to openly address the threat of AMR Debiopharm will join the action-focused discussions around […]
